Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Gross Profit (2016 - 2025)

Ptc Therapeutics has reported Gross Profit over the past 10 years, most recently at $157.7 million for Q4 2025.

  • Quarterly results put Gross Profit at $157.7 million for Q4 2025, down 19.89% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (up 199.22% YoY), and the annual figure for FY2025 was $1.7 billion, up 124.67%.
  • Gross Profit for Q4 2025 was $157.7 million at Ptc Therapeutics, down from $195.2 million in the prior quarter.
  • Over the last five years, Gross Profit for PTCT hit a ceiling of $1.2 billion in Q1 2025 and a floor of -$15.5 million in Q2 2024.
  • Median Gross Profit over the past 5 years was $176.7 million (2024), compared with a mean of $214.0 million.
  • Biggest five-year swings in Gross Profit: tumbled 107.72% in 2024 and later soared 1178.48% in 2025.
  • Ptc Therapeutics' Gross Profit stood at $155.9 million in 2021, then rose by 0.4% to $156.5 million in 2022, then surged by 77.57% to $277.9 million in 2023, then fell by 29.16% to $196.9 million in 2024, then fell by 19.89% to $157.7 million in 2025.
  • The last three reported values for Gross Profit were $157.7 million (Q4 2025), $195.2 million (Q3 2025), and $167.5 million (Q2 2025) per Business Quant data.